EXACT SCIENCES CORPO

EXAS
Delayed Nasdaq - 04:00 2022-11-28 pm EST
41.50 USD -2.70%

Turn to zoom
Prev.41.50000000
Open42.23000000
High43.23000000
Low41.08000000
Volume1 250 385
Latest news
11/15
11/14
11/08
11/07
Chart EXACT SCIENCES CORPORATION
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBearish
Resistance46,351,248,8
Spread/Res.-10%-19%-15%
Spread/Supp.9,5%37%37%
Support37,930,430,4
Financials
Sales 2022 2 035 M - -
Net income 2022 -650 M - -
Net Debt 2022 1 750 M - -
P/E ratio 2022 -11,4x
Yield 2022 -
Capitalization 7 374 M 7 374 M -
EV / Sales 2022 4,48x
EV / Sales 2023 3,99x
Nbr of Employees 6 460
Free-Float 99,1%
Company
Exact Sciences Corporation is a global cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection. It offers laboratory testing services from its Cologuard colorectal cancer screening test, Oncotype DX cancer diagnostic tests and services, and COVID-19...
Sector :
Bio Diagnostics & Testing
Calendar :
2022-11-29 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 41,50 $
Average target price 59,12 $
Spread / Average Target 42,5%